Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Biden adds weight loss drug Ozempic
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
High-dose Wegovy leads to substantial weight loss in trial
Novo Nordisk’s Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study Says
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side-effects.
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight patients lower their weight by 20.7%.
High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.
East Idaho News on MSN
12h
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
14h
on MSN
Ozempic, Wegovy are among 15 drugs selected for Medicare’s price negotiations
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
To go dark on Sunday
Cabinet approves Gaza deal
Court declares DACA illegal
Ex-CIA analyst pleads guilty
Fed exits climate group
US drops corruption case
Calls for stronger sanctions
Opposes Fani Willis' bid
To skip Trump’s inauguration
Vanguard fined by SEC
Bitcoin soars past $100K
Senate confirmation hearing
Sasaki signs with Dodgers
FTC sues PepsiCo
NHTSA probing GM vehicles
Polar vortex to freeze US
Khan gets 14-year jail term
Denied bail in assault case
Texas abortion pill ruling
Acting legend Plowright dies
Sudan army chief sanctioned
Sign partnership treaty
CA battery storage plant fire
To fill Vance’s Senate seat
Liable for defaming veteran
Commutes more sentences
Related topics
Ozempic
Medicare
Novo Nordisk
Presidency of Donald Trump
Eli Lilly
Feedback